Prophylactic steroids for paediatric open-heart surgery: a systematic review

Suzi Robertson-Malt1, Mahmoud El Barbary

  • 1JBI Collaboration, National & Gulf Centre for Evidence Based Medicine and National and Gulf Centre for Evidence Based Medicine, Riyadh, Saudi Arabia.

Insights

Prophylactic corticosteroids in pediatric open-heart surgery show weak evidence for reducing intensive care unit stay and ventilation duration. Further research is needed to clarify benefits and harms of this intervention for children.

Area of Science:

  • Pediatric Cardiac Surgery
  • Immunology
  • Pharmacology

Background:

  • Cardiopulmonary bypass in pediatric patients triggers an immune response, leading to post-operative complications like hemodynamic instability, infection, and tachyarrhythmias.
  • Corticosteroids are sometimes administered to mitigate this pro-inflammatory response, but their efficacy and safety in children remain uncertain.

Purpose of the Study:

  • To systematically review the beneficial and harmful effects of prophylactic corticosteroid administration versus placebo in pediatric open-heart surgery.

Main Methods:

  • Searched multiple databases (Cochrane, MEDLINE, EMBASE) and grey literature without language restrictions.
  • Included randomized and quasi-randomized controlled trials in pediatric patients undergoing open-heart surgery.
  • Used RevMan4.2.8 for meta-analyses with random-effects models and weighted mean difference.

Main Results:

  • All-cause mortality could not be assessed due to incomplete data.
  • Weak evidence suggests prophylactic corticosteroids may reduce intensive care unit stay, peak core temperature, and duration of ventilation.

Conclusions:

  • The clinical benefits and harms of prophylactic corticosteroids in pediatric open-heart surgery require further investigation.
  • Current evidence is limited, necessitating more comprehensive studies to guide clinical practice.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
922
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
377
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
316
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
852
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.6K